MedPath

Fasting Intervention for children with Unilateral Renal Tumours to reduce Toxicity

Recruiting
Conditions
Acute kidney injury, renal tumours
Registration Number
NL-OMON27995
Lead Sponsor
Princess Máxima Center for Paediatric Oncology (Investigator-Initiated)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Patients diagnosed with and/or a strong clinical suspicion of a unilateral malignant renal tumour without metastatic disease (either WT, RT, CCS, RCC, CMN, etc.) at Princess Máxima Centre for Paediatric Oncology. Since biopsy and therefore histological diagnosis of the type of renal tumour is not mandatory preoperatively, there needs to be a strong clinical suspicion or diagnosis of a renal tumour, opting for surgical excision after preoperative chemotherapy (treatment planned according to SIOP-RTSG-UMBRELLA).

unilateral localized renal tumours, not metachronous, planned radical tumour-nephrectomy, adequate understanding of the Dutch language.

Exclusion Criteria

Bilateral renal involvement, anorexia / very low body weight (for subjects younger than 1 year: SD-score < -2 for weight by age, for subjects older than 1 year: SD-score < -2 for weight by height), underlying metabolic disease prohibiting a period of fasting, metastatic disease, unilateral local and metachronous disease, no curative treatment possible or opting for Nephron-Sparing Surgery (NSS).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The incidence of Acute Kidney Injury (AKI) on postoperative day 3 (48-72 hours after end of anaesthesia)
Secondary Outcome Measures
NameTimeMethod
Postoperative renal function, postoperative renal injury, side effects, adherence to fasting, change in fasting parameters, body weight, subject wellbeing, physical activity, neuromotor performance, duration of postoperative hospital stay, admission to ICU, expression of cytoprotective/anti-oxidant genes.
© Copyright 2025. All Rights Reserved by MedPath